PHOTOBIOLOGY OF VITAMIN D
维生素 D 的光生物学
基本信息
- 批准号:6478946
- 负责人:
- 金额:$ 5.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Multiple sclerosis (MS) is a T-cell mediated autoimmune disease of
the central nervous system (CNS). Much research related to the
immunological aspects of MS has focused on defining the nature of the
antigen(s) against which the immune response is generated and the
molecule(s) responsible for presentation of these antigens. For many
years, the dogma has been that T-cells recognize peptide antigens
presented in the context of M11C molecules and substantial research
has defined peptide antigens that may contribute to the pathogenesis
of MS. Recently, it hasbeen shown that molecules of the CD1 family
can act as restriction elements in lipid antigen presentations to
specialized subsets of T-cells suggesting that the spectrum of
antigens to which T-cells respond may be broader than previously
thought. Studies on the identification of these antigens have thus
far been directed only to bacterial components. CD1 glycoproteins are
cell surface molecules, noncovalently linked to beta2-microglobulin
and structurally related to major histocompatibility (M11C) antigens.
The CD I family includes CD I a, b and c proteins, products of
separate genes that all map to chromosome 1, having molecular masses
of 49, 45, and 43 kDa respectively. They are found on all cortical
thymocytes, but not on circulating T-cells or monocytes, and are
differentially expressed by subpopulations of dendritic cells,
Langerhans cells (CDI a and CD I c), subsets of B-cells (CD I c),
certain T-cell leukemias, and tissue macrophages in some inflammatory
lesions. In the brain, CD I a has been reported on microglia by some
investigators, but not others. Battistini et al.. have shown that
CDlb, is expressed in active MS lesions. Since lipids, particularly
glycolipids, are a major component of the myelin membrane it is
reasonable to consider that lipids may be involved in the
immunopathology of MS. The immune response would include CD1
molecules presenting lipid antigens to specialized populations of
T-cells. To test this hypothesis, the first step is to isolate and
characterize a purified lipid antigen that elicits a T-cell response.
Recent work has suggested that the glycolipids that elicit the most
response contain unusual fatty acids and long chain bases. Therefore,
it is important to find if unusual fatty acids or long chain bases are
expressed in MS tissues.
多发性硬化症(MS)是一种T细胞介导的自身免疫性疾病,
中枢神经系统(CNS)。 许多研究与
多发性硬化症的免疫学方面侧重于定义多发性硬化症的性质。
针对其产生免疫应答的抗原,
负责呈递这些抗原的分子。 对于许多
多年来,一直认为T细胞识别肽抗原
在M11 C分子和大量研究的背景下提出的
已经确定了可能导致发病的肽抗原
最近,研究表明,CD 1家族的分子
可以作为脂质抗原呈递中的限制性元件,
特化的T细胞亚群表明,
T细胞应答的抗原可能比以前更广泛
想的 因此,对这些抗原的鉴定的研究
迄今为止仅涉及细菌成分。 CD 1糖蛋白是
细胞表面分子,与β 2-微球蛋白非共价连接
并且在结构上与主要组织相容性(M11 C)抗原相关。
CD I家族包括CD I a、B和c蛋白,
分离的基因都映射到1号染色体,具有分子质量
分别为49、45和43 kDa。 它们存在于大脑皮层
胸腺细胞,但不是循环T细胞或单核细胞,
树突细胞亚群的差异表达,
朗格汉斯细胞(CDIa和CDIc),B细胞亚群(CDIc),
某些T细胞白血病和组织巨噬细胞在一些炎症
病变 在大脑中,CD I a已经被一些人报道在小胶质细胞上
调查员,而不是其他人。 Battistini et al. 表明
CDlb在活动性MS病变中表达。 由于脂质,特别是
糖脂是髓鞘膜的主要成分,
合理地认为脂质可能参与了
免疫反应包括CD 1
将脂质抗原呈递给特定的
T细胞 为了验证这一假设,第一步是分离和
表征激发T细胞应答的纯化的脂质抗原。
最近的研究表明,糖脂,引起最
反应含有不寻常的脂肪酸和长链碱。 因此,我们认为,
重要的是要发现,如果不寻常的脂肪酸或长链碱,
在MS组织中表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL F HOLICK其他文献
MICHAEL F HOLICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL F HOLICK', 18)}}的其他基金
TOPICAL 1,25 VITAMIN D3 IN CHILDREN WITH PSORIASIS
银屑病儿童局部使用 1,25 维生素 D3
- 批准号:
6117215 - 财政年份:1998
- 资助金额:
$ 5.36万 - 项目类别:
HEXAFLUORO 1 ALPHA 25 DIHYDROXYVITAMIN D3 & DOVONEX FOR TREATING PSORIASIS
六氟 1 ALPHA 25 二羟基维生素 D3
- 批准号:
6264934 - 财政年份:1998
- 资助金额:
$ 5.36万 - 项目类别:
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS
外用六氟 1,25-二氢维生素 D3 治疗牛皮癣
- 批准号:
6117220 - 财政年份:1998
- 资助金额:
$ 5.36万 - 项目类别:
EVALUATION OF TOPICAL 24 EPI 1,25 DIHYDROXYVITAMIN D2
局部 24 EPI 1,25 二羟基维生素 D2 的评价
- 批准号:
6248479 - 财政年份:1997
- 资助金额:
$ 5.36万 - 项目类别:
相似海外基金
REU Site: University of Colorado, Engineering Smart Biomaterials
REU 站点:科罗拉多大学,工程智能生物材料
- 批准号:
2348856 - 财政年份:2024
- 资助金额:
$ 5.36万 - 项目类别:
Standard Grant
An iPSC based xeno-free platform to assess the foreign body response against new biomaterials
基于 iPSC 的无异源平台,用于评估新生物材料的异物反应
- 批准号:
NC/Y000838/1 - 财政年份:2024
- 资助金额:
$ 5.36万 - 项目类别:
Research Grant
CAREER: Developing Ultrasound-Programmable 3D-Printed Biomaterials for Spatiotemporal Control of Gene Delivery
职业:开发用于基因传递时空控制的超声波可编程 3D 打印生物材料
- 批准号:
2339254 - 财政年份:2024
- 资助金额:
$ 5.36万 - 项目类别:
Continuing Grant
Antimicrobial biomaterials from bio-based feedstocks with novel feedstock supplementation strategies
采用新型原料补充策略的生物基原料制成的抗菌生物材料
- 批准号:
10063453 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Collaborative R&D
FET: Small: Simulation-guided design of heterochiral DNA nanostructures for biomaterials applications
FET:小型:用于生物材料应用的异手性 DNA 纳米结构的模拟引导设计
- 批准号:
2312215 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Standard Grant
CAREER: Surfactant Proteins that Stabilize Biomolecular Condensates: From Biophysics to Biomaterials for Biomanufacturing
职业:稳定生物分子缩合物的表面活性剂蛋白:从生物物理学到生物制造的生物材料
- 批准号:
2238914 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Continuing Grant
CAREER: Modular Protein Origami to Build Genetically Programmable Biomaterials
职业:用模块化蛋白质折纸构建基因可编程生物材料
- 批准号:
2239927 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Continuing Grant
Pathophysiology and prevention of degeneration of heterograft biomaterials due to advanced glycation end products and serum protein infiltration
由于晚期糖基化终产物和血清蛋白浸润导致异种移植生物材料变性的病理生理学和预防
- 批准号:
10679910 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Multifunctional Intelligent Hierarchical Fibrous Biomaterials Integrated with Multimodal Biosensing and Feedback-Based Interventions for Healing Infected Chronic Wounds
多功能智能分层纤维生物材料与多模式生物传感和基于反馈的干预措施相结合,用于治愈感染的慢性伤口
- 批准号:
10861531 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
- 批准号:
10655959 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:














{{item.name}}会员




